Imperial researchers include Prof Amanda Cross & Nefeli Taravira (Surgery and Cancer), Prof Elio Riboli, Prof Marc Gunter, Sherry Morris, David Muller & Rawan Maawadh (School of Public Health), Doris Chan, Ahmed Jayedi, Kostas Tsilidis, Margarita Cariolou (WCRF CUP)
08.10.2025 13:08 β π 1 π 0 π¬ 0 π 0
Group photo showing Imperial College London researchers at the European Prospective Investigation into Cancer and Nutrition annual meeting in Rome - Professor Amanda Cross, Nefeli Taravira, Professor Elio Riboli, Professor Marc Gunter, Sherry Morris, David Muller, Rawan Maawadh, Doris Chan, Ahmed Jayedi, Kostas Tsilidis, Margarita Cariolou
Our @imperialcollegeldn.bsky.social colleagues were gathered this week for @who.int IARC EPIC annual meeting to share and discover the wide range of #cancerresearch studies being carried out across this important cohort.
@wcrf.org
08.10.2025 13:08 β π 3 π 2 π¬ 1 π 0
Cancer researcher Rawan Maawadh giving a talk with a screen behind showing her slide presentation
Also at EPIC is @imperialmed.bsky.social
#PhD candidate Rawan Maawadh (supervisor Prof Amanda Cross) giving a talk on 'Proteomic Signatures of #Obesity and their Associations with #ColorectalCancer in a Case-Cohort Study in EPIC'
07.10.2025 15:00 β π 0 π 0 π¬ 0 π 0
Cancer researcher Nefeli Taravira standing beside her research poster
Our @imperialmed.bsky.social #PhD candidate Nefeli Taravira is at Rome today for @who.int IARC EPIC annual meeting presenting her research on 'The impact of #education, #smoking and #alcohol on oesophageal squamous cell #carcinoma risk in the EPIC cohort'
07.10.2025 14:56 β π 0 π 0 π¬ 1 π 0
Congrats to @imperialsandc.bsky.social postdoc Dr Rhea Harewood on receiving the @cancerresearchuk.org Bridge to Academic Leadership Award! This award will support Rhea in building skills to pursue independent research & transition to group leadership in the field of proximal bowel cancer aetiology
23.09.2025 14:57 β π 0 π 0 π¬ 0 π 0
Thrilled to share that Fangqing Li has been awarded a China Scholarship Council @imperialcollegeldn.bsky.social Scholarship!
She'll rejoin CSPRG in July as a fully funded PhD student, focusing on early-onset colorectal cancer.
Welcome back Fangqing!
#PhD #CancerResearch @imperialsandc.bsky.social
03.07.2025 12:43 β π 1 π 0 π¬ 0 π 0
@imperialbrc.bsky.social-funded Dr Rhea Harewood & Kelly Gleason led a great #BowelCancerAwareness online session, supported by @imperialsandc.bsky.social, with Harrow THCOGIC Church members last week!
They covered bowel cancer causes, public involvement in research, & Rhea's future research plans
01.07.2025 10:25 β π 1 π 0 π¬ 0 π 0
A huge thank you to the 3 brilliant speakers (& their supportive colleagues) from @imperialnhs.bsky.social, @imperialsandc.bsky.social who joined Dr Harewood for a PPI session with 58 EKTA Harrow community members
Valuable discussions had on breast & prostate cancer awareness & current research!
30.06.2025 09:09 β π 0 π 0 π¬ 0 π 0
More @cancerresearchuk.org #PrevConf25 final day action
β
Heavyweight academics slug it out over GLP1 agonists importance (or not) for #cancerprevention
β
Prof Karen Brown weighs in on drugs for precision cancer prevention
www.cancerresearchuk.org/funding-for-...
27.06.2025 15:55 β π 1 π 0 π¬ 0 π 0
Come see our researchers present their research next week and check out our Keynote as well!!!
@imperialmed.bsky.social @imperial-csprg.bsky.social @imperial-edu.bsky.social @imperialcollegeldn.bsky.social
26.06.2025 09:06 β π 2 π 1 π¬ 0 π 0
This is the first study to show an association between distal polyp characteristics & long-term proximal colon cancer risk, helping to inform who might benefit from colonoscopy, and providing evidence for future updates of post-polypectomy surveillance guidelines.
Read it here: t.co/P6P4wA8zxF
24.06.2025 09:27 β π 2 π 2 π¬ 0 π 0
New analyses of #UKFSST data identify distal polyp characteristics associated with future proximal colon cancer risk.
Funders: @cancerresearchuk.org @nihr.bsky.social
Authors: R Harewood, K Wooldrage, E Robbins, J Kinross, C Wagner & AJ Cross
Journal: @bmj.com Open Gastroenterology
24.06.2025 09:25 β π 0 π 0 π¬ 0 π 0
New paper alert!
Larger or high-grade dysplastic distal adenomas found on flexi-sig screening are associated with β¬οΈ risk of future proximal colon cancer.
No associations for number or histology of distal adenomas or any distal hyperplastic polyp characteristics
@bmj.com OpenGastro
t.co/P6P4wA8zxF
24.06.2025 09:23 β π 0 π 0 π¬ 0 π 0
We took a break from the office to celebrate the successful PhD vivas of both Emma and Sharon with a sunny picnic! It was great to have the opportunity to mark this achievement as a group, congratulations to you both!
#PhDone
29.05.2025 14:22 β π 1 π 0 π¬ 0 π 0
Thanks @qubelfastofficial.bsky.social @helencolemanqub.bsky.social for inviting Amanda J Cross to give the Charlotte Jackson Gift Lecture today! A great opportunity to share our @cancerresearchuk.org funded work on #BowelCancer early detection & how our findings are influencing policy & patient care
22.05.2025 15:28 β π 1 π 0 π¬ 0 π 0
4 years ago... #timeflies
12.05.2025 14:39 β π 0 π 0 π¬ 0 π 0
A huge congratulations to our brilliant @imperialsandc.bsky.social
@cancerresearchuk.org #PhD - Dr Emma Robbins! - on successfully passing her #viva today!
An incredible achievement and well-deserved recognition of her hard work and dedication. We are so proud to celebrate with her!
πππ₯³
12.05.2025 14:39 β π 1 π 0 π¬ 1 π 0
Post doc Dr Rhea Harewood sharing #BowelCancerAwareness at a community outreach event with the Harrow THCOGIC church.
The group discussed how #BowelCancer is caused, how we can screen to find it earlier and how to improve public involvement in bowel cancer research
#EDI #CancerResearch
24.04.2025 10:25 β π 2 π 1 π¬ 0 π 0
Improving involvement of EDI groups in #BowelCancer research is essential to make medical research more equitable
Rhea Harewood & Kelly Gleason collaborated with the Asian Women Cancer Group to hear their opinions on Rhea's future bowel #CancerResearch plans!
#BowelCancerAwareness
23.04.2025 13:25 β π 2 π 0 π¬ 0 π 0
It's #BowelCancerAwareness Month
Spotlight on our @nihr.bsky.social post-doc Dr Rhea Harewood's work to improve involvement & participation of minority ethnic groups in #BowelCancer research
This work is funded by the @imperialsandc.bsky.social and @imperialcollegeldn.bsky.social EDI seed funds!
23.04.2025 13:23 β π 0 π 0 π¬ 0 π 0
8/8
Impact
Effective allocation of surveillance colonoscopies is crucial to protect higher-risk pts from CRC while minimising invasive procedures for low-risk pts.
Our unique data will inform recommendations for ongoing surveillance in future post-polypectomy surveillance guidelines.
07.04.2025 09:30 β π 0 π 0 π¬ 0 π 0
7/8
Conclusion
Pts with high-risk findings at both baseline & SC1 needed a second surveillance colonoscopy, whereas those with low-risk findings at SC1 did not, regardless of their baseline findings.
We couldn't draw conclusions for the LR-HR group due to limited CRC cases.
07.04.2025 09:30 β π 0 π 0 π¬ 1 π 0
6/8
Findings:
Compared to the general population, CRC incidence after SC1 was:
βͺοΈ ~0.5 times lower in the LR-LR group
βͺοΈ - Non-significantly different in the HR-LR or LR-HR groups, although the 95%CI for the LR-HR group was wide due to few CRC cases
βͺοΈ - ~3 times higher in the HR-HR group
07.04.2025 09:30 β π 0 π 0 π¬ 1 π 0
5/8
Methods
We examined CRC incidence after SC1. Median follow-up was 8 years. CRC incidence in each group was then compared with that in the general population.
07.04.2025 09:30 β π 0 π 0 π¬ 1 π 0
4/8
Methods
10,508 pts were split into 4 groups defined by their findings at baseline & at SC1
- βLow-risk, low-riskβ (LR-LR)
- βHigh-risk, low-riskβ (HR-LR)
- βLow-risk, high-riskβ (LR-HR)
- βHigh-risk, high-riskβ (HR-HR)
07.04.2025 09:30 β π 0 π 0 π¬ 1 π 0
3/8
Background
Pts at β¬οΈ risk of CRC after polyp removal are recommended to have post-polypectomy surveillance to protect against future CRC.
However, there are limited data to support recommendations for ongoing surveillance beyond SC1.
07.04.2025 09:30 β π 0 π 0 π¬ 1 π 0
2/8
What
A retrospective, cohort analysis of pts who underwent baseline colonoscopy with polyp removal & had β₯1 check-up colonoscopies (βpost-polypectomy surveillanceβ).
Authors: E Robbins, K Wooldrage, M Rutter, A Veitch & A J Cross
Funding: @cancerresearchuk.org @nihr.bsky.social
07.04.2025 09:30 β π 0 π 0 π¬ 1 π 0
1/8
Which patients under surveillance for colorectal cancer (CRC) after polyp removal need to continue having surveillance beyond the 1st surveillance colonoscopy (SC1)?
Our new analysis in Gut @BMJ.com examines which pt groups need ongoing surveillance.
gut.bmj.com/cgi/rapidpdf...
07.04.2025 09:30 β π 2 π 0 π¬ 1 π 0
At the CSPRG, we're aiming to reduce the number of people being diagnosed & dying from #ColorectalCancer
Watch this space for future work on colorectal cancer risk and diet & lifestyle, how best to screen for CRC, and how to protect those at high risk from this cancer
#CSPRGWeekOfResearch
21.03.2025 16:29 β π 1 π 0 π¬ 0 π 0
Working to reduce the burden of ill health through our world class primary care research and teaching. Established in 1997.
https://www.phpc.cam.ac.uk/research/departmental-research-units/primary-care-unit
Co-Creating Ireland's Public Involvement in Open Research Roadmap
ENGAGED is building a national roadmap to shape public involvement in open research in Ireland. We believe that research can and does play an important role in tackling societal challenges.
Researchers at LSHTM, University of Edinburgh and others. We research the tobacco, alcohol, food, fossil fuel and others. We also research cross-industry playbooks and industry misinformation.
https://www.lshtm.ac.uk/research/centres-projects-groups/cdrg
Group Leader of Cancer Immunology
University of Oxford
The Institute for Life Course & Aging at the University of Toronto facilitates research & provides graduate education on aging from a life course perspective.
Cancer epidemiologist. Interests include #NoTobacco #AlcoholAndCancer #LiverCancer #OralCancer #CDoH #PolicyImpact #Rstats #RLadies. Views my own
Research Programme Manager in Prevention and Population research at @CRUK. Messages here are my own views about science, food, aviation and random rants
Your go-to source for the latest research and fresh perspectives on endocrine and metabolic conditions. #endocrinologyjournal
IF=4.6
https://journals.sagepub.com/home/tae
Environmental Epidemiologist πAssistant Prof at OHSU-PSU School of Public Health & OHSU Knight Cancer Instituteπ Trained at Harvard Chan SPH, Dana-Farber Cancer Institute & Imperial College Londonπ¬π§ Iβm into environmental health equity π³β€οΈ Nature is healingπ
Senior Manager, Max Healthcare | PhD Candidate (Medical Research) β Max-MIME (AcSIR) | Visiting Research Fellow β PERC, SPH Imperial College London | Research Interests: Periodontal Health & Type 2 Diabetes | Public Health & Community Engagement |
Lead at NHS England for #LivingWithAndBeyondCancer.
Trustee of the Pelvic Radiation Disease Association PRDA.org.uk | Views my own | Quality of life really matters
HQIP is an independent charity and partner of the NHS that aims to improve healthcare services & patient outcomes through clinical audit and quality improvement.
Project Manager for the National Clinical Audit and Patient Outcomes Programme (NCAPOP) at the Healthcare Quality Improvement Partnership (HQIP). Views all mine.
#CAAW25: www.hqip.org.uk/clinical-audit-awareness-week
PhD in Microbiology (Virologist), too many years down the rabbit hole of comprehensive cancer control, 3x cancer survivor, genetic mutant, president of a nonprofit but opinions are my own, Lynch Syndrome and other high risk cancer pre-dispositions
Public Health Scientist and Cancer Screening Modeller,
View are my own
Previvor | Lynch Syndrome (MSH6) & CHEK2
Podcast Host π | Keynote Speaker π€
Advocating for hereditary cancer awareness & prevention
Host of The Positive Gene Podcast
#cancernurse Oncology Advanced Nurse Practitioner. PhD on hereditary cancer & health promotion. Enfermera de oncologΓa πͺπ¦π¬π§
#OncSky #canSky #NurseSky #hereditarycancer
Helping to make cancer screening more accessible for people with a Learning Disability
Specialist Screening Practitioner